tiprankstipranks
Trending News
More News >
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
US Market

West Pharmaceutical Services (WST) Income Statement

Compare
864 Followers

West Pharmaceutical Services Income Statement

Last quarter (Q3 2025), West Pharmaceutical Services's total revenue was $804.30M, an increase of 7.69% from the same quarter last year. In Q3, West Pharmaceutical Services's net income was $140.00M. See West Pharmaceutical Services’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.89B$ 2.95B$ 2.89B$ 2.83B$ 2.15B
Gross Profit
$ 1.00B$ 1.13B$ 1.14B$ 1.17B$ 767.90M
Operating Expenses
$ 407.60M$ 421.80M$ 375.40M$ 414.70M$ 348.90M
Depreciation and Amortization
$ 155.40M$ 137.30M$ 120.60M$ 122.30M$ 109.10M
EBITDA
$ 743.80M$ 844.10M$ 808.10M$ 879.70M$ 518.90M
Operating Income
$ 594.60M$ 710.90M$ 763.50M$ 758.70M$ 419.00M
Other Income/Expenses
$ 5.60M$ 4.80M$ -62.90M$ 10.30M$ -300.00K
Pretax Income
$ 600.20M$ 715.70M$ 700.60M$ 769.00M$ 418.70M
Net Income
$ 492.70M$ 593.40M$ 585.90M$ 661.80M$ 346.20M
Per Share Metrics
Basic EPS
$ 6.75$ 7.99$ 7.88$ 8.90$ 4.68
Diluted EPS
$ 6.69$ 7.88$ 7.73$ 8.67$ 4.57
Weighted Average Shares Outstanding
73.00M 74.30M 74.40M 74.40M 73.90M
Weighted Average Shares Outstanding (Diluted)
73.70M 75.30M 75.80M 76.30M 75.80M
Currency in USD

West Pharmaceutical Services Earnings and Revenue History